LIPID METABOLISM AND THERAPY: Edited by Philip C. Calder and Richard J. DeckelbaumLipids and liver dysfunction in patients receiving parenteral nutritionGabe, Simon M.a,bAuthor Information aLennard Jones Intestinal Failure Unit, St Mark's Hospital, Harrow bDepartment of Surgery and Cancer, Imperial College, London, UK Correspondence to Simon M. Gabe, Honorary Senior Lecturer, Lennard Jones Intestinal Failure Unit, St Mark's Hospital, Northwick Park, Harrow HA1 3UJ, UK. Tel: +44 20 8235 4089; e-mail: [email protected] Current Opinion in Clinical Nutrition and Metabolic Care: March 2013 - Volume 16 - Issue 2 - p 150-155 doi: 10.1097/MCO.0b013e32835dbcf4 Buy Metrics Abstract Purpose of review Abnormalities of liver function tests are common in patients with intestinal failure receiving parenteral nutrition. Lipid emulsions have been implicated in the development of hepatobiliary disease in patients receiving parenteral nutrition. Recent findings Lipid emulsions with reduced polyunsaturated fatty acids and specific ω6 : ω3 fatty acid ratios have been shown to have some beneficial effects on liver function, although the studies are small and generally of short duration in paediatric and adult patients. Summary There is good evidence to suggest that the parenteral lipid dose should be less than 1 g/kg body weight/day, but this may not apply to all patients. The evidence is presented for the different lipid emulsions and their effect on liver function. The benefit of these emulsions compared with simply giving a lower lipid dose has yet to be studied. © 2013 Lippincott Williams & Wilkins, Inc.